1. Blanco, Javier G, Leisenring, Wendy M, Gonzalez-Covarrubias, Vanessa M, Stovall, Marilyn, Bhatia, Smita. . Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. In Cancer, 112, 2789-95. doi:10.1002/cncr.23534. https://pubmed.ncbi.nlm.nih.gov/18457324/
2. Fonoudi, Hananeh, Jouni, Mariam, Cejas, Romina B, Sapkota, Yadav, Burridge, Paul W. 2024. Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes. In JACC. CardioOncology, 6, 38-50. doi:10.1016/j.jaccao.2023.11.008. https://pubmed.ncbi.nlm.nih.gov/38510289/
3. Cai, Yipin, Huang, Yu, Zhang, Jie, Huang, Haiwei, Gao, Yu. . LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway. In Neoplasma, 69, 1406-1417. doi:10.4149/neo_2022_220730N784. https://pubmed.ncbi.nlm.nih.gov/36591804/
4. Liu, Shilong, Zhan, Ning, Gao, Chunzi, Piao, Shiqi, Jing, Suwei. 2021. Long noncoding RNA CBR3-AS1 mediates tumorigenesis and radiosensitivity of non-small cell lung cancer through redox and DNA repair by CBR3-AS1 /miR-409-3p/SOD1 axis. In Cancer letters, 526, 1-11. doi:10.1016/j.canlet.2021.11.009. https://pubmed.ncbi.nlm.nih.gov/34801596/
5. Hou, Min, Wu, Nannan, Yao, Lili. 2021. LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion. In Cancer cell international, 21, 36. doi:10.1186/s12935-020-01685-y. https://pubmed.ncbi.nlm.nih.gov/33422081/
6. Yang, Mei, Chen, Wenxi, Liu, Haojie, Tang, Mingwu, Liu, Yinghui. 2022. Long Non-coding RNA CBR3 Antisense RNA 1 is Downregulated in Colorectal Cancer and Inhibits miR-29a-Mediated Cell Migration and Invasion. In Molecular biotechnology, 64, 773-779. doi:10.1007/s12033-021-00444-2. https://pubmed.ncbi.nlm.nih.gov/35107754/
智鼠故事 
